Skip to main content
Home
  • The Network
    • Membership
    • Who we are
    • Make the most of our services
    • Cambridge Cluster
    • Cambridge NeuroWorks
    • FAQ
  • Companies
    • Member directory
  • News
    • News listing
    • Blog
  • Events
    • All events
    • Cambridge Network events
    • Advertise your event
    • Boost your event
    • Sponsorship
  • Learning
    • Training courses
    • In-house courses
    • Coaching services
    • Graduate scheme
    • Consultancy services
    • Peer groups
    • Learning FAQ
  • Jobs
    • Jobs listing
    • Recruitment Packages
    • Advertise your vacancies
    • Connect with future talent
    • Boost your job
    • Tips for finding a job
More
    • Contact us
    • Join the network
    • Log in
    • The Network
      • Membership
      • Who we are
      • Make the most of our services
      • Cambridge Cluster
      • Cambridge NeuroWorks
      • FAQ
    • Companies
      • Member directory
    • News
      • News listing
      • Blog
    • Events
      • All events
      • Cambridge Network events
      • Advertise your event
      • Boost your event
      • Sponsorship
    • Learning
      • Training courses
      • In-house courses
      • Coaching services
      • Graduate scheme
      • Consultancy services
      • Peer groups
      • Learning FAQ
    • Jobs
      • Jobs listing
      • Recruitment Packages
      • Advertise your vacancies
      • Connect with future talent
      • Boost your job
      • Tips for finding a job

    Breadcrumb

    1. Home
    2. Healthcare and Life Science

    Healthcare and Life Science

    1 February 2023

    Orbit Discovery and Endevica Bio enter multi-target collaboration to advance development of cachexia therapeutics

    Orbit Discovery Limited (Orbit), a leader in the discovery of therapeutic peptide hits, today announced it has entered into a multi target Research Agreement with Endevica Bio Inc., (Endevica), a company dedicated to creating first-in-class therapeutics for cachexia caused by cancer and...

    31 January 2023

    Apply to be a mentor to a rare disease patient group leader!

    Become a mentor for a rare disease patient group leader who needs YOU and your skills! This is your chance to give something back to a community that has given so much to those living with a rare disease. Not sure what skills or advice you have to offer? Just being...

    1 February 2023

    Life Sciences Marketing Plan: Onyva The Agency

    5 Steps to a Successful Marketing Plan. With January well and truly underway, it's a good time to review your strategic marketing plan for 2023. Our article and infographic for the life sciences sector will ensure your marketing plan hits home. ...

    31 January 2023

    The Cambridge signs neurodiversity membership

    The Cambridge Building Society has become a Corporate Member of Neurodiversity in Business (NiB) with a focus on building a neuroinclusive culture. ...

    31 January 2023

    Bio-Rad’s CFX Opus Deepwell Dx Real-Time PCR System Advances Large Reaction Volume IVD Assay Development and Diagnostic Testing

    Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced the launch of the CFX Opus Deepwell Dx Real-Time PCR System, a real-time PCR system listed with the U.S. Food and Drug Administration (FDA) for in ...

    31 January 2023

    Pangaea Data Named “Digital Solution of the Year” by the UK Government’s Department for International Trade (DIT)

    Pangaea Data, (Pangaea), provider of a novel AI-driven product for characterizing patients by mapping their journeys and disease trajectories in a privacy-preserving and scalable manner, today announced that it has been named “Digital Solution of the Year” by the UK Government’s Departm...

    31 January 2023

    ARU Peterborough to celebrate female scientists

    Free event shines light on trailblazers, including Peterborough’s Daphne Jackson. ...

    31 January 2023

    Arecor announces publication of phase 1 data for AT278 in diabetes care

    Ultra-concentrated, ultra-rapid acting insulin AT278, a promising candidate in the pursuit of next generation insulins to simplify and improve glycemic control ...

    31 January 2023

    ieso Digital Health Appoints Dave Icke as Executive Chair

    Bringing more than 30 years of technology and healthcare leadership expertise including 10 years’ executive experience in digital health ieso Digital Health, the innovative healthcare company developing AI-driven evidence-based mental health solutions, announced today that David (D...

    26 January 2023

    The Golden Egg: Affordable, high spec wet lab space available NOW

    Riverlabs has got what everyone wants…

    Pagination

    • First page «
    • Previous page ‹‹
    • …
    • Page 211
    • Page 212
    • Current page 213
    • Page 214
    • Page 215
    • …
    • Next page ››
    • Last page »
    Receive our newsletter

    Footer menu

    • Terms & Conditions
    • Disclaimer
    • Privacy
    • Cookies
    • FAQ

    Cambridge Network Limited is a company registered in England under company No. 3400152

    The Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT

    Email: [email protected], Tel: 01223 746801

    © 2026 Cambridge Network. All Rights Reserved.

    Website by KISS